Singapore markets closed

Emergent BioSolutions Inc. (EBS)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
52.39-1.45 (-2.69%)
At close: 4:00PM EDT
52.50 +0.11 (0.21%)
Pre-market: 08:15AM EDT
Sign in to post a message.
  • s
    scorp
    The company reiterated over 8 usd in guidance. We’re now at close to 6.5 p/e. Why doesn’t JNJ just buy EBS for 6 billion. It’s nothing for them and they can control their vaccine manufacturing ! Plus get a profitable business

    Today’s action presents a massive disconnect that makes stocks distance themselves so greatly from the fundamental story,

    I’m baffled
  • C
    Cnote
    JNj press release…emergent likely to be a partner as jnj continues in vaccine space with RSV as well
  • s
    satch
    Easy buy here. Load up now on this beaten down stock. Profitable. With many contracts! And a COVID manufacturer and vax play.
  • C
    Cnote
    80 by year end
  • d
    d
    It's all politics. Even the pharmaceutical industry is being used as a political weapon now. The stock was at 72 with half the revenue in 2018. This is purely because EBS was aligned with J&J and those in bed with Pfizer at CDC and FDA wanted to make a little money. Would be interesting to look at the short positions of the FDA and CDC decision makers around the time when the news broke. Same with J&J news. It's all intended to favor Pfizer and paint them as the better solution in the publics mind because that's what their handlers at CDC and FDA make money on. Total corruption.
  • W
    Will
    Hating this stock more and more by the day. Does this thing know a green day?
  • W
    Will
    Is that green I'm seeing? I don't quite believe it...
  • F
    FinDic
    FDA authorizes additional batch of Johnson & Johnson vaccine from troubled Baltimore plant - Baltimore Sun

    https://www.baltimoresun.com/coronavirus/bs-md-fda-johnson-johnson-baltimore-batch-20210909-pttd7ypd3rhznmhfbj7fjujesy-story.html
    Baltimore Sun - We are currently unavailable in your region
    www.baltimoresun.com
  • F
    FinDic
    Today was an opportunity for me to load up. Too low. If you can wait until earnings, should see a nice reversal. Just one good quarter to get buying volume back in
  • s
    scorp
    Lots of market maker manipulation dump shares only to buy them back .. then keep at it
  • s
    satch
    Soon people will be noticing this one rise 20-30% and then jump on. Get in now before it’s back to 120
  • F
    FinDic
    Dow Jones Newswires: Emergent Plans to Resume Covid-19 Vaccine Production at Baltimore Plant.

    WASHINGTON -- Emergent BioSolutions Inc. plans to resume Covid-19 vaccine production at its Baltimore plant after getting the green light from the Food and Drug Administration, according to a statement from the company and an FDA letter reviewed by the Journal.

    "We are proud to be resuming production of bulk Covid-19 vaccine batches following additional reviews and collaboration with FDA and our manufacturing partners," Emergent CEO Robert Kramer said in a statement late Wednesday. "We are grateful for the opportunity to help bring this global pandemic to an end."
  • C
    Cnote
    So company is worth less than prior to pandemic? Makes no sense
  • s
    satch
    Cmon go green FFS
  • F
    FinDic
    Source: Benzinga

    Chardan Research Maintains Buy Rating On Emergent BioSolutions Inc. With $92 Price Target
  • R
    Rmani
    nice recovery today from this morning. what changed?
  • M
    MJ34
    yeah, not selling for 10 years. I paid $64 after a 60% pull back..